The Tumor Suppressor p53 in Mucosal Melanoma of the Head and Neck

被引:8
作者
Fritsche, Marie Kristin [1 ]
Knopf, Andreas [1 ]
机构
[1] Tech Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Ismaningerst 22, D-81675 Munich, Germany
关键词
mucosal melanoma; p53; Puma; N-ras; pathway; apoptosis; CUTANEOUS MELANOMAS; PUMA; APOPTOSIS; PROTEIN; CHLOROQUINE; INHIBITION; EXPRESSION; PATHWAY; TARGET;
D O I
10.3390/genes8120384
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Despite worldwide prevention programs, the incidence for cutaneous melanoma is continuously increasing. Mucosal melanoma (MM) represents a rare but highly aggressive phenotype of common melanoma with predilection in the sinonasal system. Far away from ultraviolet sun exposure, the molecular mechanisms underlying tumorigenesis and the highly aggressive clinical behavior are poorly understood. In many solid malignomas of the head and neck region, p53 tumor suppressor functions as oncogene due to p53 protein stabilizing mutation. Interestingly, the vast majority of MM demonstrates constitutively expressed p53 protein, with protein stabilizing mutations being rare. Abrogated activation of p53 target genes results in derogation of the apoptotic signal cascade and contributes to the strong resistance against chemotherapeutic agents activating p53 dependent apoptosis. The current review illustrates the role of p53 and its pathway in MM.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53
    Rho, Seung Bae
    Lee, Jeong Heon
    Park, Mi Sun
    Byun, Hyun-Jung
    Kang, Sokbom
    Seo, Sang-Soo
    Kim, Joo-Young
    Park, Sang-Yoon
    FEBS LETTERS, 2011, 585 (01) : 29 - 35
  • [22] Cross talk between stimulated NF-κB and the tumor suppressor p53
    Schneider, G.
    Henrich, A.
    Greiner, G.
    Wolf, V.
    Lovas, A.
    Wieczorek, M.
    Wagner, T.
    Reichardt, S.
    von Werder, A.
    Schmid, R. M.
    Weih, F.
    Heinzel, T.
    Saur, D.
    Kraemer, O. H.
    ONCOGENE, 2010, 29 (19) : 2795 - 2806
  • [23] Functional characterization of p53β and p53γ, two isoforms of the tumor suppressor p53
    Graupner, Vilma
    Schulze-Osthoff, Klaus
    Essmann, Frank
    Jaenicke, Reiner U.
    CELL CYCLE, 2009, 8 (08) : 1238 - 1248
  • [24] The p53 Tumor Suppressor and Copper Metabolism: An Unrevealed but Important Link
    Tsymbal, S. A.
    Refeld, A. G.
    Kuchur, O. A.
    MOLECULAR BIOLOGY, 2022, 56 (06) : 979 - 992
  • [25] Tumor suppressor p53 stole the AKT in hypoxia
    Yun, Zhong
    Glazer, Peter M.
    JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (06) : 2264 - 2266
  • [26] Grail as a molecular determinant for the functions of the tumor suppressor p53 in tumorigenesis
    Chen, Y-C
    Chan, Jy-H
    Chiu, Y-L
    Liu, S-T
    Lozano, G.
    Wang, S-L
    Ho, C-L
    Huang, S-M
    CELL DEATH AND DIFFERENTIATION, 2013, 20 (05) : 732 - 743
  • [27] BBC3 is down-regulated with increased tumor size independently of p53 expression in head and neck cancer
    Tajnik, Mojca
    Strazisar, Mojca
    Volavsek, Metka
    Bostjancic, Emanuela
    Glavac, Damjan
    CANCER BIOMARKERS, 2012, 11 (05) : 197 - 208
  • [28] PEPD is a pivotal regulator of p53 tumor suppressor
    Yang, Lu
    Li, Yun
    Bhattacharya, Arup
    Zhang, Yuesheng
    NATURE COMMUNICATIONS, 2017, 8
  • [29] p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes
    Pappas, Kyrie
    Xu, Jia
    Zairis, Sakellarios
    Resnick-Silverman, Lois
    Abate, Francesco
    Steinbach, Nicole
    Ozturk, Sait
    Saal, Lao H.
    Su, Tao
    Cheung, Pamela
    Schmidt, Hank
    Aaronson, Stuart
    Hibshoosh, Hanina
    Manfredi, James
    Rabadan, Raul
    Parsons, Ramon
    MOLECULAR CANCER RESEARCH, 2017, 15 (08) : 1051 - 1062
  • [30] Death squads enlisted by the tumour suppressor p53
    Michalak, E
    Villunger, A
    Erlacher, M
    Strasser, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 331 (03) : 786 - 798